BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Muscatello DJ, Wang Q, Yang P, Pan Y, Huo D, Liu Z, Zhao X, Tang Y, Li C, Chughtai AA, MacIntyre CR. Hospitalizations for Influenza-Associated Severe Acute Respiratory Infection, Beijing, China, 2014-2016. Emerg Infect Dis 2018;24:2098-102. [PMID: 30334719 DOI: 10.3201/eid2411.171410] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Song CL, Wang T, Ye YL, Du JR, Li SH, Zhu JM. Etiological and epidemiological characteristics of severe acute respiratory infection caused by multiple viruses and Mycoplasma pneumoniae in adult patients in Jinshan, Shanghai: A pilot hospital-based surveillance study. PLoS One 2021;16:e0248750. [PMID: 33750952 DOI: 10.1371/journal.pone.0248750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yang J, Atkins KE, Feng L, Baguelin M, Wu P, Yan H, Lau EHY, Wu JT, Liu Y, Cowling BJ, Jit M, Yu H. Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis. BMC Med 2020;18:90. [PMID: 32284056 DOI: 10.1186/s12916-020-01545-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Gao D, Niu M, Wei SZ, Zhang CE, Zhou YF, Yang ZW, Li L, Wang JB, Zhang HZ, Zhang L, Xiao XH. Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection. Front Pharmacol 2020;11:746. [PMID: 32523531 DOI: 10.3389/fphar.2020.00746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
4 Al Amad M, Almoayed K. Influenza circulating viruses, positivity rate and risk factors for influenza associated severe acute respiratory infection during 2018/2019 winter season, Yemen. BMC Infect Dis 2022;22:111. [PMID: 35105332 DOI: 10.1186/s12879-022-07090-2] [Reference Citation Analysis]
5 Liu D, Leung K, Jit M, Wu JT. Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities. Vaccine 2021;39:5490-8. [PMID: 34454783 DOI: 10.1016/j.vaccine.2021.08.057] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhu G, Xu D, Zhang Y, Wang T, Zhang L, Gu W, Shen M. Epidemiological characteristics of four common respiratory viral infections in children. Virol J 2021;18:10. [PMID: 33407659 DOI: 10.1186/s12985-020-01475-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li J, Wang C, Ruan L, Jin S, Ye C, Yu H, Zhu W, Wang X. Development of influenza-associated disease burden pyramid in Shanghai, China, 2010-2017: a Bayesian modelling study. BMJ Open 2021;11:e047526. [PMID: 34497077 DOI: 10.1136/bmjopen-2020-047526] [Reference Citation Analysis]
8 Panahi MH, Parsaeian M, Mansournia MA, Gouya MM, Jafarzadeh Kohneloo A, Hemmati P, Fotouhi A. Detection of influenza epidemics using hidden Markov and Serfling approaches. Transbound Emerg Dis 2021;68:2446-54. [PMID: 33152160 DOI: 10.1111/tbed.13912] [Reference Citation Analysis]
9 Stark FC, Akache B, Ponce A, Dudani R, Deschatelets L, Jia Y, Sauvageau J, Williams D, Jamshidi MP, Agbayani G, Wachholz K, Harrison BA, Li X, Krishnan L, Chen W, Mccluskie MJ. Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization. Vaccine 2019;37:7108-16. [DOI: 10.1016/j.vaccine.2019.07.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
10 Li J, Chen Y, Wang X, Yu H. Influenza-associated disease burden in mainland China: a systematic review and meta-analysis. Sci Rep 2021;11:2886. [PMID: 33536462 DOI: 10.1038/s41598-021-82161-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sun W, Kirkpatrick E, Ermler M, Nachbagauer R, Broecker F, Krammer F, Palese P. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach. J Virol 2019;93:e00333-19. [PMID: 30944178 DOI: 10.1128/JVI.00333-19] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
12 Peng F. COVID-19: The experience from Beijing, China. Clin Dermatol 2021;39:9-11. [PMID: 33972058 DOI: 10.1016/j.clindermatol.2020.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]